Factor Xa Inhibitor Discontinuation for Minimal– or Low–Bleeding Risk Procedures
This cohort study investigates the safety and effectiveness of the standardized PERIXa protocol for perioperative discontinuation of factor Xa inhibitors among patients with atrial fibrillation undergoing procedures with minimal or low bleeding risk.